Related Experiment Videos
Drug-induced acute liver disease
M G Lee1, B Hanchard, N P Williams
1Department of Medicine, University Hospital, University of the West Indies, Kingston, Jamaica.
Postgraduate Medical Journal
|June 1, 1989
Summary
Drug-induced liver injury (DILI) affects many patients, presenting with jaundice and abnormal liver enzymes. Prompt drug withdrawal leads to recovery in most cases, highlighting DILI
Area of Science:
- Hepatology
- Clinical Pharmacology
- Toxicology
Background:
- Drug-induced liver injury (DILI) is a significant clinical concern.
- Accurate diagnosis and management are crucial for patient outcomes.
Purpose of the Study:
- To report findings on drug-induced acute liver disease.
- To identify common causative agents and clinical presentations.
- To evaluate the efficacy of drug withdrawal in DILI management.
Main Methods:
- Retrospective analysis of 53 patients diagnosed with drug-induced acute liver disease.
- Clinical data collection including demographics, symptoms, liver function tests, and histology.
- Review of patient outcomes following cessation of suspected causative agents.
Main Results:
- The study included 35 females and 18 males (mean age 41).
- Jaundice and abnormal liver enzymes were prevalent (98% and 96%, respectively).
- Cholestatic injury (72%) predominated over cytotoxic damage (28%).
- Common culprits included methyldopa, chlorpropamide, chlorpromazine, halothane, and oral contraceptives (60% of cases).
- Fifty-one patients recovered after drug withdrawal; two died from hepatic failure.
Conclusions:
- Drug-induced liver injury should be strongly considered in patients with hepatic disease.
- Early recognition and withdrawal of the offending drug are critical for recovery.
- The majority of DILI cases demonstrate good prognosis with timely intervention.